An antidepressant from the ’50s, repurposed to fight prostate cancer, lowered PSA levels in men with recurrent disease, pilot study shows.
An antidepressant from the ’50s, repurposed to fight prostate cancer, lowered PSA levels in men with recurrent disease, pilot study shows.